Skip to main content
Home
Home

  • People
  • Events
    AI in Health Conference_Banner Image
    Science and Technology Policy
    Tue, Sep. 15 - Thu, Sep. 17, 2026 | 8 am - 6 pm
    AI in Health Conference See Details
    SynBio-Crop
    Science and Technology Policy
    Fri, Sep. 18, 2026 | 9 am - 5 pm
    Synthetic Biology at the Intersection of Science, Ethics, and Policy See Details
    Ellen Ochoa Image
    Science and Technology Policy
    Mon, Nov. 02, 2026 | 5:30 pm - 7:30 pm
    Joni Sue Lane Lecture Series — Exploring Space: A Conversation With Astronaut Ellen Ochoa See Details
  • Podcasts
  • Research Programs
  • Research & Commentary
  • Press
  • Support
  • About
  • Newsletter
  • Search
  • Research
  • Twitter
  • Facebook
  • instagram
  • Linkedin
  • Youtube
  • Newsletter
  • Economics & Finance
  • Energy
  • Foreign Policy
  • Domestic Policy
  • Health & Science
  • All Publications
Baker Briefing | Science and Technology Policy | Podcast

How Risky Is Gain-of-Function Research, Really?

April 1, 2025 | Alicia L. Johnson, Kirstin R.W. Matthews, Yousif Shamoo, David M. Satterfield
DNA strand being altered

Table of Contents

Author(s)

Alicia L. Johnson

Civic Science Postdoctoral Associate

Kirstin R.W. Matthews

Fellow in Science and Technology Policy

Yousif Shamoo

Ralph and Dorothy Looney Professor of BioSciences, Rice University

David M. Satterfield

Director, Baker Institute for Public Policy | Janice and Robert McNair Chair in Public Policy

Share this Publication

  • Facebook
  • Twitter
  • Email
  • Linkedin
  • Print This Publication

Tags

Science and technologyCOVID19Science researchBaker Briefing

“The possibility [of a gain-of-function pathogen being accidentally released] is very low due to the oversight, the many oversight mechanisms that we do have … And it’s worth noting too that most gain-of-function experiments that are occurring are not inherently risky, and they don’t involve pandemic pathogens. The bigger concern that we should be having at this time is with the rapid changes in the cuts that are happening in our government, [which] could lower the strength of the oversight.” — Alicia L. Johnson, Ph.D.

About the Episode

Debates around gain-of-function research, which genetically alters an organism to give it new functions, became highly visible during the COVID-19 pandemic, when public figures began to speculate that the virus responsible was created through gain-of-function experiments in Wuhan, China.

However, many scientists maintain that this kind of research helps us understand and respond to emerging viral threats, like avian flu. So just how important is gain-of-function research, and what oversight mechanisms are in place to reduce the hazards that yet other scientists say make these experiments too risky?

The Baker Institute Science and Technology Policy Program’s Kirstin R.W. Matthews and Alicia L. Johnson, along with Rice University biosciences professor Yousif Shamoo, joined the “Baker Briefing” podcast to discuss the risks, benefits, and guardrails surrounding gain-of-function research — and why federal budget cuts and layoffs could make the endeavor less secure.

This conversation was recorded on March 20, 2025. Subscribe and listen to “Baker Briefing” on Apple, Spotify, or wherever you listen to podcasts.

Transcript

A full transcript of this episode is available here. This transcript was AI-generated and has not been through editorial review.

About ‘Baker Briefing’

Hosted by David M. Satterfield,  the “Baker Briefing” podcast delivers timely analysis on breaking policy developments and other critical policy issues of the day in conversations with experts at the Baker Institute. New episodes are released weekly.

Certain episodes of “Baker Briefing” are recorded in front of a live audience at Rice University in Houston, Texas. These recordings are free and open to the public. To learn about upcoming recordings and other public programming from the Baker Institute, subscribe to our “Events Digest” newsletter, delivered weekly.

 

 

This material may be quoted or reproduced without prior permission, provided appropriate credit is given to the author(s) and Rice University’s Baker Institute for Public Policy. The views expressed herein are those of the individual author(s) and do not necessarily represent the views of Rice University’s Baker Institute for Public Policy.

© 2025 Rice University’s Baker Institute for Public Policy
  • Print This Publication
  • Share
    • Facebook
    • Twitter
    • Email
    • Linkedin

Related Research

Washington D.C., USA - February 29, 2020: Sign of U.S. Department of Health and Human Services at their headquarters building in Washington, D.C.
Baker Briefing | Podcast

One Year In, How Trump and RFK Jr. Reshaped Federal Health Policy

Read More
Healthcare business investment, medical insurance, coverage planning, hospital payment support.
Baker Briefing | Podcast

Why Health Insurance Costs Vary So Dramatically

Read More
IDLIB, SYRIA - Jun 17, 2013: Internally displaced child Syrian refugees
Baker Briefing | Podcast

The Human Cost of Escalating Conflict in the Middle East

Read More
  • Contact Us
  • Donate Now
  • Press
  • Membership
  • Careers
  • Student Opportunities
  • About the Institute
  • Rice.edu

6100 Main Street
Baker Hall MS-40, Suite 120
Houston, TX 77005

Email: [email protected]
Phone: 713-348-4683
Fax: 713-348-5993

  • Twitter
  • Facebook
  • instagram
  • Linkedin
  • Youtube
  • Newsletter
  • © Rice University's Baker Institute for Public Policy
  • Web Accessibility
  • Privacy Policy